Article 55

1. The Executive Director shall be appointed by the Management Board, on a proposal from the Commission, for a period of five years, which shall be renewable. 2. The Executive Director shall be the legal representative of the Agency. He shall be responsible: for the day-to-day administration of the Agency, for the provision of appropriate technical support for the Committee for Proprietary Medicinal Products and the Committee for Veterinary Medicinal Products, and their working parties and expert groups, for ensuring that the time limits laid down in Community legislation for the adoption of opinions by the Agency are respected, for ensuring appropriate coordination between the Committee for Proprietary Medicinal Products and the Committee for Veterinary Medicinal Products, for the preparation of the statement of revenue and expenditure and the execution of the budget of the Agency, for all staff matters. 3. Each year, the Executive Director shall submit to the Management Board for approval, while making a distinction between the Agency's activities concerning medicinal products for human use and those concerning veterinary medicinal products: a draft report covering the activities of the Agency in the previous year, including information about the number of applications evaluated within the Agency, the time taken for the completion of the evaluation and the medicinal products authorized, rejected or withdrawn, a draft programme of work for the coming year, the draft annual accounts for the previous year, the draft budget for the coming year. 4. The Executive Director shall approve all financial expenditure of the Agency.

← 2. · All articles · 1. →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.